View of An Open-Labelled Randomized Clinical Trial to evaluate the efficacy of Siddha drug - Vettummaaran Kuligai with Nilavembu Kudineer (VMK-NVK) in the Management of Mild to Moderate COVID-19 (SARS-CoV2 infection)

Return to Issue Details An Open-Labelled Randomized Clinical Trial to evaluate the efficacy of Siddha drug - Vettummaaran Kuligai with Nilavembu Kudineer (VMK-NVK) in the Management of Mild to Moderate COVID-19 (SARS-CoV2 infection) Download Download PDF